RedHill Biopharma (RDHL) Asset Utilization Ratio (2013 - 2023)

RedHill Biopharma (RDHL) has 11 years of Asset Utilization Ratio data on file, last reported at 0.76 in Q2 2023.

• On a quarterly basis, Asset Utilization Ratio rose 69.8% year-over-year to 0.76 in Q2 2023; TTM through Jun 2023 was 0.76, a 69.8% increase from a year earlier, with the FY2025 full-year figure at 0.01, down 96.63% from the prior year.
• Asset Utilization Ratio for Q2 2023 stood at 0.76, up from 0.48 in the prior quarter.
• Over the last five years, Asset Utilization Ratio for RDHL reached as high as 0.76 in Q2 2023 and fell as low as 0.05 in Q1 2020.
• Historically, Asset Utilization Ratio has averaged 0.34 across 5 years, with a median of 0.39 in 2021.
• Across the five-year window, Asset Utilization Ratio plunged 59.38% in 2020 and soared 712.54% in 2021, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.11 in 2019, then jumped by 234.97% to 0.37 in 2020, then gained by 26.61% to 0.47 in 2021, then declined by 16.2% to 0.39 in 2022, then jumped by 94.75% to 0.76 in 2023.
• Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.76 in Q2 2023, 0.48 in Q1 2023, and 0.39 in Q4 2022.